Page 802 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat

758 INDEX INDEX

California encephalitis, 167 Carbidopa, 549 Cardiogenic shock, 310 muscular dystrophy, 61
Calluses (dermatology), 475 Carbohydrate absorption, 373 etiology, 310 rubella, 182
cAMP (cyclic adenosine Carbohydrate metabolism Cardiomegaly sorbitol, 81
monophosphate) inborn errors of, 80 Pompe disease, 87 Catecholamines
endocrine hormone messenger, Carbol fuchsin, 125 Cardiomyopathy, 308 adrenal medulla secretion, 327
337 Carbon dioxide (CO ) β-blockers, 245 amphetamines and, 242
2
fructose bisphosphatase-2 and, 76 production in tissues, 127 Chagas disease, 158 contractility effects of, 284
heat-labile/heat-stable toxin effects, retention, 679 drug reaction and, 248 ephedrine and, 242
132 transport, 670 familial amyloid, 212 heart contractility, 284
hyperparathyroidism, 345 Carbonic anhydrase, 670 glycogen storage diseases, 87 pacemaker action potential, 292
PTH effect on, 332 Carbon monoxide (CO) heart failure with, 309 pheochromocytoma and, 350
Vibrio cholerae, 146 vs cyanide poisoning, 667 hemochromatosis and, 395 Catecholamine synthesis
CAMP factor, 137 electron transport inhibition, 78 hypertrophic, 245 tyrosine catabolism, 83
Campylobacter spp poisoning, 666 Kussmaul sign in, 316 Cats (disease vectors)
animal transmission, 149 teratogenicity, 614 Starling curves, 285 Campylobacter jejuni, 145
bloody diarrhea, 179 toxicity treatment, 248 sudden cardiac death, 304 Cat scratch disease, 149
jejuni, 145 Carbon tetrachloride Cardiotoxicity Pasteurella multocida, 149, 186
reactive arthritis and, 469 free radical injury and, 210 doxorubicin, 439 Tinea corporis, 152
Canagliflozin, 353 Carboplatin drugs causing, 444 Toxoplasma gondii, 156, 182
Canalicular stage (development), 660 mechanism and clinical use, 442 methylxanthines, 687 Cauda equina, 507
Cancer toxicities of, 444 TCA adverse effects, 575 Cauda equina syndrome, 530
common metastases, 223 Carboplatin toxicity, 444 trastuzumab, 443 Caudal fold closure defects, 358
deaths from, 272 Carboxylases, 73 Cardiovascular drugs Caudal regression syndrome, 614
ESR in, 214 Carboxypeptidase, 373 naming conventions for, 253 Caudate
hallmarks of, 221 Carcinoembryonic antigen (CEA) reactions to, 248 basal ganglia, 500
immune evasion in, 221 (tumor marker), 226 Cardiovascular system, 281–323 Huntington disease, 520
mortality of, 222 Carcinogens, 225 anatomy, 283 Cavernous hemangiomas
pneumoconioses, 676, 677 griseofulvin, 200 embryology, 281–283 liver, 392
Cancer drugs Carcinoid syndrome, 352 pathology, 298–313 Cavernous hemangiomas (liver), 392
cell cycle, 438 bronchial carcinoid tumors, 684 pharmacology, 316–322 Cavernous sinus, 542
targets, 438 somatostatin in treatment, 371 physiology, 284–299 dural venous sinuses, 503
Cancer epidemiology, 222 Carcinoid tumors sclerosis of, 473 syndrome, 542
Candesartan, 610 biomarkers for, 226 Carditis thrombosis with mucormycosis,
Candida albicans, 153 immunohistochemical stains for, Lyme disease, 146 153
HIV-positive adults, 177 227 rheumatic fever, 312 CCR5 protein
T cell dysfunction, 116 octreotide for, 400 Carfilzomib, 443 HIV and, 175
Candida spp stomach, 379 Carina (trachea), 663 maraviroc, 203
amphotericin B, 199 Carcinoma in situ, 219 Carmustine, 441 viral receptor, 166
azoles, 199 cervical dysplasia, 645 pulmonary fibrosis, 251 CD4+ cell count
echinocandins, 200 ductal, 650 Carnitine acyltransferase I, 73, 89 disease associations by levels, 177
immunodeficiency infections, 118 neoplastic progression, 219 Carotid artery CD4 protein, 101
osteomyelitis, 180 penis, 651 atherosclerosis in, 302 viral receptor, 166
tricuspid valve endocarditis and, vulvar, 644 cavernous sinus, 542 CD4+ T cells (HIV), 176
311 Carcinomas emboli from, 538 CD5 protein, 432
vulvovaginitis, 181 bone, 464 embryonic development, 619 CD8 protein, 101
Candidiasis colorectal, 388 giant cell arteritis and, 314 CD16 protein, 101
Candida albicans, 153 invasive, 219 Carotid massage, 296 CD20 protein, 110
chronic mucocutaneous, 116 metastases of, 219, 223 Carotid sinus, 296 in CLL, 432
cortisol and, 336 nomenclature of, 220 Carpal bones, 449 CD21 protein, 110
nystatin, 199 thyroid, 343 Carpal tunnel syndrome, 459 viral receptor, 166
Cannibalism, 178 Cardiac arrest lunate dislocation, 449 CD25 protein
“Cannonball” metastases, 642 antacid adverse effects, 399 nerve injury, 447 cell surface protein, 110
Capecitabine hypermagnesemia, 591 rheumatoid arthritis, 466 regulatory T cells and, 102
5-F-dUMP, 36 Cardiac cycle, 287 Carteolol, 552 CD28 protein, 110
“Cape-like” sensory loss, 492 Cardiac depression, 318 Cartilage CD34 protein, 110
Capillary fluid exchange, 297 Cardiac function curves, 286 collagen in, 50 leukocyte extravasation and, 215
Capitate bone, 449 Cardiac glycosides fluoroquinolone damage to, 250 CD40 protein, 110
Capitation, 271 mechanism and clinical use, 321 Cartilage damage, 204 CDKN2A gene, 224
Caplan syndrome, 466, 677 sodium-potassium pump Carvedilol, 245, 323 CEA tumor marker, 388
Capsules (bacterial), 124 inhibition, 49 Casal necklace, 67 Cefaclor, 189
Captain’s wheel Cardiac looping, 280 Caseating granulomas Cefazolin
Paracoccidioidomycosis, 151 Cardiac output in tuberculosis, 140 mechanism and use, 189
Captopril, 610 exercise and, 670 Case-control studies, 256 prophylaxis, 198
Caput medusae, 365 in pregnancy, 633 Caseous necrosis, 209 Cefepime
Carbachol, 240, 552 variables in, 284 Caspases, 208 mechanism and use, 189
Carbamazepine V/Q mismatch and, 669 Caspofungin Pseudomonas aeruginosa, 143
agranulocytosis, 250 Cardiac output equations, 285 echinocandins, 200 Cefotaxime, 189
aplastic anemia, 250 Cardiac pressures (normal), 297 Casts in urine, 594 Cefotetan
cytochrome P-450 and, 252 Cardiac tamponade, 310 Catabolism of amino acids, 82 mechanism and use, 189
epilepsy, 544 aortic dissection and, 303 Catalase, 210 Cefoxitin
SIADH and, 249 jugular venous pulse in, 287 Catalase-positive organisms, 128 mechanism and use, 189
Carbamoyl phosphate, 82 MI, 305, 307 Cataplexy, 568 Cefpodoxime
Carbamoyl phosphate synthetase, 73 shock, 310 Cataracts, 535 mechanism and use, 189
Carbapenems Cardiac therapy, 317 corticosteroid toxicity, 120 Ceftaroline
mechanism and use, 190 Cardiac tumors, 316 diabetes mellitus and, 346 mechanism and use, 189
Pseudomonas aeruginosa, 143 Cardinal veins, 281 galactosemia, 80 MRSA, 198

FAS1_2019_21_Index_749-806.indd 758 11/21/19 12:27 PM